S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation

Autor: Mo Chen, Ping Zheng, Mengjia Hu, Changhong Du, Junping Wang, Yu He, Shuguang Pan, Jin Zhu, Yang Xu, Peng Jiang, Jinchi Cui, Yujun Zhang, Ying Hu, Jie Bai, Jiejuan Lai
Rok vydání: 2019
Předmět:
Male
Vascular Endothelial Growth Factor A
0301 basic medicine
Cancer Research
Cell
Apoptosis
Metastasis
Cholangiocarcinoma
Mice
chemistry.chemical_compound
0302 clinical medicine
Tumor Cells
Cultured

Mice
Inbred BALB C

vascular endothelial growth factor
Liver Neoplasms
NF-kappa B
Cell migration
Articles
Middle Aged
Cell cycle
Prognosis
Gene Expression Regulation
Neoplastic

Survival Rate
Vascular endothelial growth factor
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
cardiovascular system
Female
Corrigendum
Signal Transduction
Mice
Nude

Biology
03 medical and health sciences
Downregulation and upregulation
parasitic diseases
Biomarkers
Tumor

medicine
metastasis
S100 calcium-binding protein A8
Animals
Humans
Calgranulin A
Cell Proliferation
NF-κB pathway
Oncogene
medicine.disease
Xenograft Model Antitumor Assays
Toll-Like Receptor 4
030104 developmental biology
Bile Duct Neoplasms
chemistry
Tumor progression
Cancer research
Follow-Up Studies
Zdroj: International Journal of Oncology
ISSN: 1791-2423
1019-6439
DOI: 10.3892/ijo.2019.4907
Popis: A growing body of evidence indicates that S100 calcium‑binding protein A8 (S100A8) is frequently overexpressed in malignant tumor tissues and regulates tumor progression; however, the role of S100A8 in cholangiocarcinoma (CCA) remains unclear. The present study demonstrated that the protein expression of S100A8 was significantly higher in pathological tissues compared with adjacent normal tissues from patients with CCA. In addition, S100A8 expression was significantly associated with differentiation, lymph node metastasis and poor prognosis in patients following surgical resection of CCA. Furthermore, both in vitro and in vivo experiments revealed that overexpression of S100A8 promoted, while S100A8 knockdown attenuated, the migration and metastasis of CCA cells. Of note, the present results indicated that S100A8 promoted the CCA tumor cell‑induced migration of vascular endothelial cells. Finally, S100A8 was demonstrated to positively regulate the expression of vascular endothelial growth factor (VEGF) in CCA cells, which was mediated by activation of the Toll‑like receptor 4 (TLR4)/NF‑κB pathway. In conclusion, the present study demonstrated that S100A8 had an important role in facilitating CCA cell migration and metastasis via upregulation of VEGF expression by activating the TLR4/NF‑κB pathway. These findings may provide a novel target for CCA treatment.[the original article was published in International Journal of Oncology 56: 101‑112, 2020; DOI: 10.3892/ijo.2019.4907].
Databáze: OpenAIRE